The binding of transcription factors NKX3.1 and YY1 to the PCAT19 promoter leads to strong enhancer activity and activation of lncRNA PCAT19, thereby promoting tumor growth and metastasis of prostate cancer (25). This evidence concerns the gene PCAT19 and prostate carcinoma.